Core Viewpoint - The company, Yahui Long (688575.SH), has signed a strategic cooperation framework agreement with Shenzhen Brain-Machine Starlink Technology Co., Ltd. to jointly develop brain-machine interface-related products and enhance treatment technologies for central nervous system diseases [1] Group 1: Strategic Cooperation - The strategic cooperation aims to integrate brain-machine interface technology with clinical and market resources to advance product development and market expansion [1] - The partnership is expected to enhance the company's competitiveness in the field of central nervous system diseases and expand its strategic layout in brain-machine interface-related areas [1] Group 2: Company Profile of Brain-Machine Starlink - Brain-Machine Starlink focuses on both non-invasive and invasive technology paths, driven by artificial intelligence, and aims to establish a comprehensive development system from basic research to industrial application [1] - The company has developed various products, including EEG collection and analysis instruments, brain-machine interface sleep aids, sleep monitoring devices, and vagus nerve stimulation devices [1] Group 3: Market and Product Development - The collaboration will leverage both parties' strengths to accelerate the development of diagnostic products for Alzheimer's disease, autism, depression, and other neurological disorders [1] - The integration of hardware terminals, algorithm models, and cloud services is part of the strategic vision for advancing brain-machine interface applications [1]

Core Viewpoint - The company Yahui Long (688575.SH) has signed a strategic cooperation framework agreement with Shenzhen Brain-Machine Starlink Technology Co., Ltd. to jointly develop brain-machine interface-related products and enhance treatment technologies for central nervous system diseases [1] Group 1: Strategic Cooperation - The strategic cooperation aims to integrate brain-machine interface technology with clinical and market resources [1] - The collaboration will focus on the development of products related to brain-machine interfaces and promote market expansion [1] - This partnership is expected to enhance the company's competitiveness in the field of central nervous system diseases [1] Group 2: Company Profile of Brain-Machine Starlink - Brain-Machine Starlink is driven by artificial intelligence and focuses on both non-invasive and invasive technology paths [1] - The company aims to establish a full-chain development system from basic research to technology transformation and industrial implementation [1] - It has developed products such as EEG collection and analysis instruments, brain-machine interface sleep aids, and vagus nerve stimulation devices [1] Group 3: Long-term Development Strategy - The strategic cooperation aligns with the company's long-term development strategy and benefits all shareholders [1] - The collaboration is expected to expand the company's strategic layout in the brain-machine interface field [1]

Market Performance - The Hang Seng Index (HSI) rose by 8 points or 0.03% to close at 26,347 points, after fluctuating between a low of 26,256 points and a high of 26,445 points during the day[1] - The Shanghai Composite Index increased by 54 points or 1.4%, closing at 4,023 points, with a total trading volume of 1.07 trillion yuan[2] - The S&P 500 Index gained 43 points or 0.6%, reaching a new high of 6,902 points[2] Currency and Economic Indicators - The RMB/USD central parity rate was adjusted up by 58 points to 7.0230[2] - The ISM Manufacturing PMI for December fell to 47.9, marking the lowest level since October 2024, and below the market expectation of 48.3[3] Corporate Developments - China National Airlines sold 108 million shares of Cathay Pacific at a price of 12.22 HKD per share, a 6.6% discount to the closing price, raising approximately 1.32 billion HKD[5] - Chifeng Jilong Gold Mining expects a net profit of 3 to 3.2 billion RMB for 2025, an increase of 70%-81% year-on-year, driven by a 49% rise in gold product prices[5] - Hon Hai Precision Industry reported a 22% year-on-year increase in Q4 revenue to 2.6 trillion TWD (approximately 82.6 billion USD), exceeding analyst expectations[6]

Market Overview - The Hang Seng Index is expected to fluctuate around 26,000 points due to anticipated interest rate cuts by the Federal Reserve and a cautious outlook on corporate earnings in Hong Kong [1] - The U.S. Federal Reserve announced a 0.25% interest rate cut, marking the third consecutive reduction, with projections for one more cut in 2026 and 2027 [3][5] - The Chinese service sector's PMI dropped to 52 in December, indicating the weakest expansion rate in six months, while the composite PMI slightly increased to 51.3 [7] Company News - Alibaba (9988) is applying visual AI technology in the restaurant sector to compete with Meituan (3690) for market share [9] - Sunny Optical (2382) is considering a spin-off of its automotive optical business for a separate listing in Hong Kong [9] - China National Airlines (0753) reduced its stake in Cathay Pacific (0293) by over 6%, realizing approximately 1.3 billion HKD [3] Sector Focus - The National Development and Reform Commission (NDRC) is promoting new economic growth points in quantum technology, hydrogen energy, and brain-computer interfaces [2][7] - The biopharmaceutical sector in China saw a record high in new drug licensing transactions last year, indicating sustained demand [6] - The insurance sector is benefiting from strong A-share performance, leading to improved investment returns [6] IPO Market Outlook - PwC forecasts that Hong Kong will see around 150 new IPOs in 2026, raising between 320 billion to 350 billion HKD, potentially ranking among the top three globally [7] Real Estate Market - In December 2025, Hong Kong recorded 8,999 property sale contracts, a 26.4% increase month-on-month, with a total value of 65 billion HKD [8] - The Centaline Property Index reached a 19-month high, reflecting ongoing positive sentiment in the real estate market [8]

Company Recommendations - The report recommends buying shares of 高偉電子 (1415) at a current price of 29.86 HKD, with a short-term target price of 34.10 HKD, indicating a potential upside of 17.6% [7][9] - The company is expected to enter the rear camera module business in the second half of 2024, which is anticipated to drive revenue and profit growth in the first half of 2025, potentially leading to an earnings surprise [9] - The management's outlook on products in the smart driving and robotics sectors is also seen as a potential catalyst for growth [9] Valuation Insights - The current price corresponds to a forecasted P/E ratio of 17.6x for FY25E and 13.3x for FY26E, with FY26E valuation being 30% lower than the 5-year average [9] - The market expects a compound annual growth rate of 29.8% in revenue and 38.6% in net profit from FY24 to FY27E [9] Market Overview - The Hang Seng Index has shown resilience, recovering above the 10-day and 20-day moving averages, closing at 25,081 points with a trading volume of 245.7 billion HKD [5] - The report notes that the overall market sentiment remains positive, with active trading across different sectors despite limited improvement in corporate earnings [5][6] Macro Focus - China's exports in July increased by 7.2%, surpassing expectations, although exports to the U.S. fell by 21.7%, indicating potential challenges ahead [10] - The People's Bank of China is expected to continue implementing liquidity measures to maintain a stable financial environment, including a recent 700 billion RMB reverse repurchase operation [10] Industry Developments - The report highlights the upcoming World Robot Conference and the anticipated launch of Apple's iPhone 17, which may impact the mobile device sector [6] - Companies like 中芯 (0981) and 華虹 (1347) have reported mixed earnings, with 中芯's quarterly profit down by 19.5% and 華虹's profit growth falling short of expectations [11]